Zolchoice

Zolchoice Overdosage

zoledronic acid

Manufacturer:

Getwell Pharma

Distributor:

Pharma 518

Marketer:

Ambica
Full Prescribing Info
Overdosage
Acute overdosage with Zoledronic acid for Injection may cause clinically significant hypocalcemia, hypophosphatemia and hypomagnesemia. By the intravenous administration of calcium gluconate, potassium or sodium phosphate and magnesium sulfate, clinically relevant reductions in serum levels of calcium, phosphorus, and magnesium respectively should be corrected. The other effects of overdosage include hyperthermia, paresthesia, abnormal liver functions and renal toxicity.